FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

150911000001104: Hypovase 2mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16541701000001115 Hypovase 2mg tablets (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16541801000001112 Hypovase 2mg tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hypovase 2mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Is a Product containing precisely prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Has active ingredient Prazosin hydrochloride false Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Is a Hypovase true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Prazosin true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Has specific active ingredient Prazosin hydrochloride true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) Has basis of strength substance Prazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Hypovase 2mg tablets (Pfizer Ltd) 56 tablet 4 x 14 tablets Is pack of False Hypovase 2mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Hypovase 2mg tablets (Pfizer Ltd) 56 tablet 4 x 14 tablets Has AMP True Hypovase 2mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start